GVM±R in Patients With Relapsed or Refractory Aggressive NHL

NCT05299164 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma

Interventions

DRUG: Liposomal Mitoxantrone Hydrochloride dose level 1
DRUG: Liposomal Mitoxantrone Hydrochloride dose level 2
DRUG: Liposomal Mitoxantrone Hydrochloride dose level 3
DRUG: Liposomal Mitoxantrone Hydrochloride dose level 4

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]